TG Therapeutics: How a Setback for Roche Offers New Market Opportunities for the US Biotech

Multiple sclerosis (MS) is a chronic disease of the central nervous system, where the protective covering of nerve fibers is gradually damaged. This disrupts the signals between the brain and the body, leading to various physical and neurological complaints. The most common form of this disease, called RRMS, is characterized by phases in which new symptoms flare up or existing complaints worsen. According to the National Multiple Sclerosis Society, around 1 million people in the USA currently live with MS. About 85% of them are initially diagnosed...